Tyrosine kinase inhibitor compositions and methods for...

Details Tyrosine kinase inhibitor compositions and methods for... Tyrosine kinase inhibitor compositions and methods for...

C - Chemistry, Metallurgy

07

K

C07K 16/28 (2006.01)

Patent

CA 2600375

A new ErbB-based ligand binding molecule is disclosed along with its method of preparation and use. The binding molecule is a protein expressed from a recombinant DNA molecule. The protein contains an ErbB extracellular domain that binds to activating ligands. These binding elements act as traps to bind and sequester circulating ligands, thus making them unavailable for binding to cellular ErbB receptors.

L'invention concerne une molécule de liaison de ligand à base de ErbB, ainsi qu'un procédé de préparation et d'utilisation de celle-ci. La molécule de liaison est une protéine exprimée à partir d'une molécule d'ADN recombinante. La protéine renferme un domaine extracellulaire ErbB se liant à des ligands activateurs. Ces éléments de liaison agissent comme piège aux fins de liaison et de séquestre de ligands circulant, les rendant ainsi non disponibles pour la liaison à des récepteurs cellulaires ErbB.

Affiliated with

Also associated with

Rating

Tyrosine kinase inhibitor compositions and methods for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tyrosine kinase inhibitor compositions and methods for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tyrosine kinase inhibitor compositions and methods for... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1618217